NCT06337760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- European Institute of Oncology Milan, Italy
Clinical trial condition
Carcinoma, Neuroendocrine
Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.
109 public trials
31 recruiting studies
Carcinoma, Neuroendocrine trial results
Enrolling by Invitation
RegisterNET - A Registry for Neuroendocrine Tumors in the USA and Worldwide
NCT02270567
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +15 more
- Locations
-
- Wren Laboratories Branford, Connecticut, United States
Not Yet Recruiting
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
NCT07713732
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +33 more
- Locations
-
- COBL Clinical Trials - Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
- Cabrini Hospital Malvern Malvern, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
Not Yet Recruiting
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
NCT07712094
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Baotou Cancer Hospital Baotou, Inner Mongolia, China
- The First People's Hospital of Horqin District, Tongliao City Tongliao, Inner Mongolia, China
- Shanxi Bethune Hospital Taiyuan, Shanxi, China
- Tianjin First Central Hospital Tianjin, China
Not Yet Recruiting
Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms
NCT07684170
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +9 more
- Locations
-
Not specified
Not Yet Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
NCT07488923
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
- Locations
-
- Hackensack University Medical Center Hackensack, New Jersey, United States
- NYU Langone Health New York, United States
- Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States
- UT Southwestern Medical Center Dallas, Texas, United States
Not Yet Recruiting
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
NCT07595913
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Not Yet Recruiting
A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung
NCT07561645
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
- Locations
-
Not specified
Not Yet Recruiting
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
NCT06941480
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
NCT07337447
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +7 more
- Locations
-
- CHU Amiens Picardie Amiens, France
- CHU Avicenne APHP Bobigny, France
- CHU Caen Normandie Caen, France
- Hôpital Beaujon Clichy, France